Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early lumbar drainage plus intrathecal urokinase for poor-grade aneurysmal subarachnoid hemorrhage
ChiCTR2400080583Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Feb 2024
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of urokinase in subarachnoid hemorrhage (SAH) (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: mRS score 0-2. Started Feb 2024; status: recruiting.
02
Drugs
urokinase
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on ChiCTR2400080583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080583.